Oncologic Outcome after Cessation or Dose Reduction of Capecitabine in Patients with Colon Cancer

PURPOSE: Oral capecitabine has been used as adjuvant therapy for colorectal cancer patients since the 1990s. Patient-initiated cessation or reduced use of capecitabine occurs widely for various reasons, yet the consequences of these actions are unclear. The present study sought to clarify treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Jung-A, Kim, Hee Cheol, Son, Hyun-Sook, Kim, Hyoung Ran, Yun, Hae Ran, Cho, Yong Beom, Yun, Seong Hyeon, Lee, Woo Yong, Chun, Ho-Kyung
Formato: Texto
Lenguaje:English
Publicado: The Korean Society of Coloproctology 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998011/
https://www.ncbi.nlm.nih.gov/pubmed/21152231
http://dx.doi.org/10.3393/jksc.2010.26.4.287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998011/
https://www.ncbi.nlm.nih.gov/pubmed/21152231
http://dx.doi.org/10.3393/jksc.2010.26.4.287

Ejemplares similares